Concepedia

Liza B. John

LB

Statistics

Publications

14

Citations

2.4K

H-Index

14

Active since

2009

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Monash University

Centre Hospitalier de l’Université de Montréal

The University of Queensland

Liza B. John is an author at Peter MacCallum Cancer Centre specializing in immunology, cancer immunotherapy, and tumor immunology.

Publications per year

2009–2018

14

Publications

14

Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells

Liza B. John, Christel Devaud, Connie P.M. Duong et al. · Clinical Cancer Research · 2013 · 700 citations

, , +17

Blockade of A <sub>2A</sub> receptors potently suppresses the metastasis of CD73 <sup>+</sup> tumors

Paul A. Beavis, Upulie Divisekera, Christophe Paget et al. · Proceedings of the National Academy of Sciences · 2013 · 343 citations · Full text

, , +17

Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

Paul A. Beavis, Nicole Milenkovski, Melissa A. Henderson et al. · Cancer Immunology Research · 2015 · 329 citations

, , +17

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

Paul A. Beavis, Melissa A. Henderson, Lauren Giuffrida et al. · Journal of Clinical Investigation · 2017 · 321 citations · Full text

, , +17

Blockade of PD-1 immunosuppression boosts CAR T-cell therapy

Liza B. John, Michael H. Kershaw, Phillip K. Darcy · OncoImmunology · 2013 · 133 citations · Full text

, , +16

1–5 of 14